5GC-22173-52921
3 vaccinations
2 coded responses
13 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 242 / VA
- Registered
- 2021-12-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Moderna
-
2021-03-30
Dose 2 — Moderna
-
2021-12-07
Registered in v-safe
-
2021-12-07
Dose 3 — Moderna
- 2021-12-07
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-12-10
- 2021-12-11
- 2021-12-16
- 2021-12-21
- 2021-12-28
-
2022-01-04
Survey response — day 28, dose 3MedDRA: Headache, Nasal congestion, Paranasal sinus discomfort, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny and stuffy nose, sinus pressure, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-13
- 2022-01-18
-
2022-03-10
Survey response — 3 months, dose 3MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Gave birthMedDRA releases: 2024-11 · check-in free text available
-
2022-03-10
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-03-14
- 2022-06-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Moderna | No |
| 2 | 2021-03-30 | Moderna | No |
| 3 | 2021-12-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-10 | Unsuccessful |
Free text
Release 10 — day 28, dose 3
Symptoms: Runny and stuffy nose, sinus pressure, headache
Release 11 — 3 months, dose 3
Symptoms: Gave birth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release